Neurogene
NGNE
NGNE
45 hedge funds and large institutions have $53.5M invested in Neurogene in 2018 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 16 increasing their positions, 6 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0.18% more ownership
Funds ownership: 3.69% → 3.88% (+0.18%)
48% less call options, than puts
Call options by funds: $268K | Put options by funds: $520K
Holders
45
Holding in Top 10
–
Calls
$268K
Puts
$520K
Top Buyers
| 1 | +$3.27M | |
| 2 | +$1.47M | |
| 3 | +$1.13M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$823K |
| 5 |
D.E. Shaw & Co
New York
|
+$816K |
Top Sellers
| 1 | -$3.58M | |
| 2 | -$1.01M | |
| 3 | -$1.01M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$683K |
| 5 |
UONDDL
University of Notre Dame du Lac
South Bend,
Indiana
|
-$569K |